Inhibition of this microRNA might improve response to newer diabetes drugs, such as Byetta, Victoza, Trulicity, Januvia, Onglyza and Tradjenta.
UAB Hospital continues to be highly ranked by U.S. News and World Report, and is noted as the No. 1 hospital in Alabama.
A multidisciplinary research team at UAB looks to address obesity as it is genetically passed from mother to child.
Five faculty members in the School of Medicine have been named the 2016 class of James A. Pittman Jr., M.D., Scholars, a program organized to recognize the contributions of junior faculty and support the retention of highly competitive scientists and physician-scientists.
Many patients diagnosed with type 1 diabetes as adults do not fit the standard profile for a diabetes diagnosis; they are younger, are relatively fit and have little if any belly fat.
The new program offers a team approach to weight management, in which the physician, dietitian, behaviorist and exercise trainer play critical roles in helping the patient achieve goals.
Discovery leads researchers to redouble efforts to design a new class of drugs to treat diabetes.